NCT06595004View on ClinicalTrials.gov

A Study to Evaluate the Efficacy and Safety of HCP1004 in Chronic Low-Back Pain Patients

PHASE3RecruitingINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

November 20, 2024

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Chronic Low-back Pain
Interventions
DRUG

HCP1004

Test Drug

DRUG

RLD2401

Reference drug

Trial Locations (1)

04763

RECRUITING

Hanyang University Seoul Hospital, Seongdong-Gu

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY